drugset
drugset / Trial / NCT04322175

Pharmacokinetic and Tolerance Study of Meloxicam Eye Drops in Healthy Volunteers

NCT04322175 ↗

Phase 1 Unknown 80 enrolled Beijing Tongren Hospital
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The pharmacokinetics, safety, and tolerability of meloxicam eye drops in Chinese healthy volunteers were evaluated to provide a basis for the formulation of a phase II clinical trial dosing regimen for this product. Including pre-tests and formal trials, formal trials include single-dose pharmacokinetics tests and multiple-dose tolerance tests (4 times a day for 3 consecutive days).

Timeline

Start
2019-12-16
Primary completion
2020-06-01
Completion
2020-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Meloxicam Small molecule 0.1 % Other

Indications

No indication recorded.